PHOENIX -- A subcutaneous infusion of efgartigimod cut the risk of relapse in patients with a rare but serious immune-mediated neuropathy, according to the phase II ADHERE trial. Patients with ...

The amplitude of compound muscle action potential and the density of myelinated fibers were significantly reduced in patients with ATTR-PN compared with patients with nutritional or alcoholic ...

IVIg and other treatments for chronic inflammatory demyelinating polyneuropathy (CIDP) slow or stop your immune systems attack on the protective coating (myelin sheath) around your nerves. But ...

Background: Management of chronic inflammatory demyelinating polyneuropathy (CIDP) is challenged by heterogeneity in severity, comorbidities, potential adverse effects, and treatment accessibility.

In a new study, researchers found that among patients with diabetic peripheral neuropathy (DPN) and low serum vitamin B12 levels, 16 weeks of daily vitamin B12 supplementation significantly improved ...